These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 6972772)
21. [Combined use of drugs and variations in action in various animals (author's transl)]. Van Genderen H Tijdschr Diergeneeskd; 1975 Jan; 100(1):25-36. PubMed ID: 1089001 [No Abstract] [Full Text] [Related]
22. Synthesis of some novel pyrazole derivatives as potential antiinflammatory agents with minimum ulcerogenic activity. el-Hawash SA; el-Mallah AI Pharmazie; 1998 Jun; 53(6):368-73. PubMed ID: 9675765 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and pharmacological evaluation of a novel series of 5-(substituted)aryl-3-(3-coumarinyl)-1-phenyl-2-pyrazolines as novel anti-inflammatory and analgesic agents. Khode S; Maddi V; Aragade P; Palkar M; Ronad PK; Mamledesai S; Thippeswamy AH; Satyanarayana D Eur J Med Chem; 2009 Apr; 44(4):1682-8. PubMed ID: 18986738 [TBL] [Abstract][Full Text] [Related]
24. Antiinflammatory, analgesic and hypoglycemic effects of Mangifera indica Linn. (Anacardiaceae) stem-bark aqueous extract. Ojewole JA Methods Find Exp Clin Pharmacol; 2005 Oct; 27(8):547-54. PubMed ID: 16273134 [TBL] [Abstract][Full Text] [Related]
25. Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 2: General pharmacological properties. Zwagemakers JM; Claassen V Arzneimittelforschung; 1980; 30(9):1526-34. PubMed ID: 7193021 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and pharmacological evaluation of pyrazoline derivatives as new anti-inflammatory and analgesic agents. Amir M; Kumar H; Khan SA Bioorg Med Chem Lett; 2008 Feb; 18(3):918-22. PubMed ID: 18182288 [TBL] [Abstract][Full Text] [Related]
27. General pharmacological profile of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N -methylbenzamide. Hirohashi M; Takasuna K; Kasai Y; Usui C; Tamura K; Kojima H Arzneimittelforschung; 1993 May; 43(5):569-77. PubMed ID: 8329002 [TBL] [Abstract][Full Text] [Related]
29. [Pharmacological properties of new derivatives of 1-(2'-morpholine-ethyl)-4-phenyl-4-acylpiperidine]. Szadowska A; Tokarska H Acta Pol Pharm; 1970; 27(4):405-15. PubMed ID: 4394285 [No Abstract] [Full Text] [Related]
30. Transsynovial kinetics of lonazolac and its hydroxy metabolite in synovitis patients. Deneke J; Luckow V; Guserle R; Pässler HH Int J Clin Pharmacol Ther; 1998 Aug; 36(8):418-24. PubMed ID: 9726694 [TBL] [Abstract][Full Text] [Related]
34. [Pharmacological properties of alkyl derivatives of 1-(p-carbo-n butoxyphenyl)-3-hydroxy-1H-indazoles]. Zoni G; Caliari W Farmaco Sci; 1969 Nov; 24(11):965-79. PubMed ID: 5363326 [No Abstract] [Full Text] [Related]
35. [On the pharmacological action spectrum of some new hydrazine derivatives]. Fermum R Acta Biol Med Ger; 1966; 16(2):169-77. PubMed ID: 5982348 [No Abstract] [Full Text] [Related]